Clinical Trial Update: Lung Function and Patient Preference With QVA149 vs. Tiotropium in COPD Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing QVA149 (indacaterol/glycopyrronium) with tiotropium in COPD patients, focusing on lung function and patient preference; results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• QVA149 (indacaterol/glycopyrronium)
• Spiriva (tiotropium)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Obstructive Pulmonary Disease, COPD | Phase 4 | Status: COMPLETED | Results posted: 2016-01-20